Own experience of primary mediastinal B-large cell lymphoma treatment

Own experience of primary mediastinal B-large cell lymphoma treatment

Show other versions (1)

Due to the relative low incidence of primary mediastinal B-large cell lymphoma (PM BLCL) optimal approaches to its treatment is still not well developed. Possibility to improve PM BLCL clinical outcomes by intensifying induction chemotherapy (CT) and the use of rituximab, the usefulness of high-CT w...

Full description

Bibliographic Details
Main Authors: M. A. Vernyuk, N. G. Tyurina, O. A. Pavlova, A. M. Chervontseva, N. V. Zhukov
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Onkogematologiâ
Subjects:
primary mediastinal b-large cell lymphoma
macop-b
rituximab
autologous stem cell transplantation
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/14

Internet

https://oncohematology.abvpress.ru/ongm/article/view/14

Similar Items